A rare case of Graves' disease during regular hemodialysis.
We report a case of Graves' disease in a patient on regular hemodialysis. The patient also suffered from Wolff-Parkinson-White (WPW) syndrome and paroxysmal atrial fibrillation, which may both have been manifestations of the Graves' disease because of the increased oxygen demand. To our knowledge, this is the first case to illustrate the usefulness of the antithyroid agent propylthiouracil for Graves' disease complicated by endstage renal disease (ESRD) and WPW syndrome.
Maruyama
Seitaro
S
Division of Endocrinology and Metabolism, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. s-maruyama@sagamihara-hosp.gr.jp
Ikarashi
Tomoo
T
Soda
Satoshi
S
Toya
Maki
M
Okamura
Kazuki
K
Hirayama
Satoshi
S
Suzuki
Katsunori
K
Hanyu
Osamu
O
Sakurabayashi
Tai
T
Nakagawa
Osamu
O
Aizawa
Yoshifusa
Y
D013956:Antithyroid Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications*; D006111:Graves Disease / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011441:Propylthiouracil / Q000627:therapeutic use; D006435:Renal Dialysis; D014927:Wolff-Parkinson-White Syndrome / Q000150:complications*
D013956:Antithyroid Agents; D011441:Propylthiouracil